| Dr Matthew Thomas Smetanick, DO | |
|
200 John Hoover Pkwy, Bldg 4, Suite B, Burnet, TX 78611 | |
| (512) 930-3909 | |
| (512) 869-5868 |
| Full Name | Dr Matthew Thomas Smetanick |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 20 Years |
| Location | 200 John Hoover Pkwy, Burnet, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306023114 | NPI | - | NPPES |
| N4111 | Other | TX | TX MEDICAL LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | OS014480 (Pennsylvania) | Secondary |
| 207N00000X | Dermatology | N4111 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Rollins Brook Community Hospital | Lampasas, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mountain West Derm - Blackhart Pllc | 1153609813 | 103 |
News Archive
Researchers in Hong Kong and the U.S. say a new strain of the H5N1 bird flu virus has emerged in China and what is more of a worry is the strain appears to be resistant to vaccines.
Scientists funded by the Wellcome Trust have identified a key mechanism that enables malaria-infected red blood cells to stick to the walls of blood vessels and avoid being destroyed by the body's immune system. The research, published today in the journal Cell, highlights an important potential new target for anti-malarial drugs.
Nabi Biopharmaceuticals announced today that the European Patent Office upheld the Company's opposition to European Patent No. 1,329,226 (Hapten Carrier Conjugates for Use in Drug Abuse Therapy) requesting revocation of this patent. The EPO revoked this patent in its entirety.
Giving pregnant women in the developing world a daily supplement containing 10 vitamins and five minerals could help increase the birthweight of their babies, concludes a study published online by The Lancet.
› Verified 1 days ago
| Entity Name | Mountain West Derm - Austin Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396267332 PECOS PAC ID: 8628344280 Enrollment ID: O20171026000092 |
News Archive
Researchers in Hong Kong and the U.S. say a new strain of the H5N1 bird flu virus has emerged in China and what is more of a worry is the strain appears to be resistant to vaccines.
Scientists funded by the Wellcome Trust have identified a key mechanism that enables malaria-infected red blood cells to stick to the walls of blood vessels and avoid being destroyed by the body's immune system. The research, published today in the journal Cell, highlights an important potential new target for anti-malarial drugs.
Nabi Biopharmaceuticals announced today that the European Patent Office upheld the Company's opposition to European Patent No. 1,329,226 (Hapten Carrier Conjugates for Use in Drug Abuse Therapy) requesting revocation of this patent. The EPO revoked this patent in its entirety.
Giving pregnant women in the developing world a daily supplement containing 10 vitamins and five minerals could help increase the birthweight of their babies, concludes a study published online by The Lancet.
› Verified 1 days ago
| Entity Name | Mountain West Derm - Blackhart Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366018848 PECOS PAC ID: 1153609813 Enrollment ID: O20211018000436 |
News Archive
Researchers in Hong Kong and the U.S. say a new strain of the H5N1 bird flu virus has emerged in China and what is more of a worry is the strain appears to be resistant to vaccines.
Scientists funded by the Wellcome Trust have identified a key mechanism that enables malaria-infected red blood cells to stick to the walls of blood vessels and avoid being destroyed by the body's immune system. The research, published today in the journal Cell, highlights an important potential new target for anti-malarial drugs.
Nabi Biopharmaceuticals announced today that the European Patent Office upheld the Company's opposition to European Patent No. 1,329,226 (Hapten Carrier Conjugates for Use in Drug Abuse Therapy) requesting revocation of this patent. The EPO revoked this patent in its entirety.
Giving pregnant women in the developing world a daily supplement containing 10 vitamins and five minerals could help increase the birthweight of their babies, concludes a study published online by The Lancet.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Matthew Thomas Smetanick, DO 4513 Williams Dr, Georgetown, TX 78633-1302 Ph: (512) 930-3909 | Dr Matthew Thomas Smetanick, DO 200 John Hoover Pkwy, Bldg 4, Suite B, Burnet, TX 78611 Ph: (512) 930-3909 |
News Archive
Researchers in Hong Kong and the U.S. say a new strain of the H5N1 bird flu virus has emerged in China and what is more of a worry is the strain appears to be resistant to vaccines.
Scientists funded by the Wellcome Trust have identified a key mechanism that enables malaria-infected red blood cells to stick to the walls of blood vessels and avoid being destroyed by the body's immune system. The research, published today in the journal Cell, highlights an important potential new target for anti-malarial drugs.
Nabi Biopharmaceuticals announced today that the European Patent Office upheld the Company's opposition to European Patent No. 1,329,226 (Hapten Carrier Conjugates for Use in Drug Abuse Therapy) requesting revocation of this patent. The EPO revoked this patent in its entirety.
Giving pregnant women in the developing world a daily supplement containing 10 vitamins and five minerals could help increase the birthweight of their babies, concludes a study published online by The Lancet.
› Verified 1 days ago